Meury William
Insider CIK 1536778 · SNDX Director · ACT See Remarks · KRTX President and CEO, Director · FRX SVP - Marketing · INCY Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INCY INCYTE CORP | A Award deriv | 2026-07-16 | 2026-07-20 | 80,421 | — | $0 | 80,421 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2026-07-16 | 2026-07-20 | 77,148 | — | $0 | 77,148 | SEC↗ |
| INCY INCYTE CORP | A Award | 2026-07-16 | 2026-07-20 | 26,807 | — | $0 | 183,129 | SEC↗ |
| INCY INCYTE CORP | F Tax w/h | 2026-07-02 | 2026-07-07 | 4,779 | $116.86 | $558.5K | 156,322 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2026-04-15 | 2026-04-17 | 125,000 | — | $0 | 161,101 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2025-07-02 | 2025-07-02 | 125,000 | — | $0 | 125,000 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2025-07-02 | 2025-07-02 | 108,303 | — | $0 | 108,303 | SEC↗ |
| INCY INCYTE CORP | A Award | 2025-07-02 | 2025-07-02 | 36,101 | — | $0 | 36,101 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2025-06-26 | 2025-06-30 | 110,630 | — | $0 | 110,630 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award | 2025-02-05 | 2025-02-07 | 25,000 | — | $0 | 90,000 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | D To issuer deriv | 2024-03-18 | 2024-03-18 | 63,065 | $136.81 | $8.63M | 0 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | D To issuer deriv | 2024-03-18 | 2024-03-18 | 38,688 | $330.00 | $12.77M | 0 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | D To issuer | 2024-03-18 | 2024-03-18 | 10,342 | $330.00 | $3.41M | 19,037 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | D To issuer | 2024-03-18 | 2024-03-18 | 19,037 | $330.00 | $6.28M | 0 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | A Award deriv | 2024-02-13 | 2024-02-15 | 38,688 | — | $0 | 38,688 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award | 2024-02-07 | 2024-02-09 | 17,000 | — | $0 | 65,000 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | F Tax w/h | 2023-12-28 | 2023-12-29 | 8,694 | $316.30 | $2.75M | 29,379 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise deriv | 2023-08-02 | 2023-08-03 | 24,000 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise deriv | 2023-08-02 | 2023-08-03 | 35,000 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise deriv | 2023-08-02 | 2023-08-03 | 24,000 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | S Sale | 2023-08-02 | 2023-08-03 | 35,000 | $20.46 | $716.1K | 48,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise | 2023-08-02 | 2023-08-03 | 24,000 | $7.88 | $189.1K | 72,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | S Sale | 2023-08-02 | 2023-08-03 | 24,000 | $20.46 | $491.0K | 48,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise | 2023-08-02 | 2023-08-03 | 24,000 | $9.47 | $227.3K | 72,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise | 2023-08-02 | 2023-08-03 | 35,000 | $7.11 | $248.8K | 83,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | S Sale | 2023-08-02 | 2023-08-03 | 24,000 | $20.45 | $490.8K | 48,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award | 2023-02-02 | 2023-02-03 | 16,000 | — | $0 | 48,000 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 63,065 | — | $0 | 63,065 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | A Award | 2023-01-03 | 2023-01-05 | 38,073 | — | $0 | 38,073 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award | 2022-02-02 | 2022-02-03 | 16,000 | — | $0 | 32,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award | 2021-02-03 | 2021-02-05 | 16,000 | — | $0 | 16,000 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 21,621 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 12,304 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 10,089 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 19,278 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 1 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 1,387 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 26,506 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 1,246 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 509 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 16,081 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer | 2020-05-08 | 2020-05-11 | 7,434 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer | 2020-05-08 | 2020-05-11 | 25,201 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2020-04-03 | 2020-04-07 | 855 | $175.71 | $150.2K | 32,635 | SEC↗ |
| AGN Allergan plc | A Award | 2020-03-02 | 2020-03-04 | 21,667 | $193.84 | $4.20M | 33,490 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2020-02-12 | 2020-02-14 | 24,000 | — | $0 | 24,000 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2019-12-31 | 2020-01-02 | 1,504 | $191.17 | $287.5K | 11,823 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2019-06-10 | 2019-06-12 | 24,000 | — | $0 | 24,000 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2019-04-03 | 2019-04-05 | 871 | $145.71 | $126.9K | 13,327 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2018-12-31 | 2019-01-03 | 1,531 | $133.66 | $204.6K | 14,198 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2018-09-25 | 2018-09-27 | 35,000 | — | $0 | 35,000 | SEC↗ |
| AGN Allergan plc | M Exercise deriv | 2018-05-17 | 2018-05-21 | 19,785 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | M Exercise deriv | 2018-05-17 | 2018-05-21 | 1,467 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | M Exercise | 2018-05-17 | 2018-05-21 | 19,785 | $68.11 | $1.35M | 40,154 | SEC↗ |
| AGN Allergan plc | S Sale | 2018-05-17 | 2018-05-21 | 24,425 | $154.59 | $3.78M | 15,729 | SEC↗ |
| AGN Allergan plc | M Exercise | 2018-05-17 | 2018-05-21 | 1,467 | $68.11 | $99.9K | 20,369 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2018-04-03 | 2018-04-05 | 819 | $164.74 | $134.9K | 18,902 | SEC↗ |
| AGN Allergan plc | M Exercise deriv | 2018-02-14 | 2018-02-16 | 1,957 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | M Exercise deriv | 2018-02-14 | 2018-02-16 | 17,381 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | M Exercise deriv | 2018-02-14 | 2018-02-16 | 2,765 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | M Exercise deriv | 2018-02-14 | 2018-02-16 | 1,510 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | S Sale | 2018-02-14 | 2018-02-16 | 4,700 | $162.22 | $762.4K | 42,521 | SEC↗ |
| AGN Allergan plc | S Sale | 2018-02-14 | 2018-02-16 | 7,200 | $163.04 | $1.17M | 35,321 | SEC↗ |
| AGN Allergan plc | S Sale | 2018-02-14 | 2018-02-16 | 2,000 | $164.62 | $329.2K | 33,321 | SEC↗ |
| AGN Allergan plc | S Sale | 2018-02-14 | 2018-02-16 | 13,600 | $165.16 | $2.25M | 19,721 | SEC↗ |
| AGN Allergan plc | S Sale | 2018-02-14 | 2018-02-16 | 1,000 | $161.10 | $161.1K | 47,221 | SEC↗ |
| AGN Allergan plc | S Sale | 2018-02-14 | 2018-02-16 | 2,400 | $159.82 | $383.6K | 48,221 | SEC↗ |
| AGN Allergan plc | S Sale | 2018-02-14 | 2018-02-16 | 1,700 | $158.78 | $269.9K | 50,621 | SEC↗ |
| AGN Allergan plc | S Sale | 2018-02-14 | 2018-02-16 | 1,200 | $157.60 | $189.1K | 52,321 | SEC↗ |
| AGN Allergan plc | S Sale | 2018-02-14 | 2018-02-16 | 25,079 | $157.18 | $3.94M | 53,521 | SEC↗ |
| AGN Allergan plc | M Exercise | 2018-02-14 | 2018-02-16 | 17,381 | $66.20 | $1.15M | 78,600 | SEC↗ |
| AGN Allergan plc | M Exercise | 2018-02-14 | 2018-02-16 | 1,510 | $66.20 | $100.0K | 61,219 | SEC↗ |
| AGN Allergan plc | M Exercise | 2018-02-14 | 2018-02-16 | 2,765 | $51.07 | $141.2K | 59,709 | SEC↗ |
| AGN Allergan plc | M Exercise | 2018-02-14 | 2018-02-16 | 1,957 | $51.07 | $99.9K | 56,944 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2017-12-29 | 2018-01-02 | 1,611 | $163.58 | $263.5K | 55,410 | SEC↗ |
| AGN Allergan plc | M Exercise deriv | 2017-12-01 | 2017-12-04 | 2,535 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | M Exercise deriv | 2017-12-01 | 2017-12-04 | 9,272 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | S Sale | 2017-12-01 | 2017-12-04 | 2,535 | $173.89 | $440.8K | 57,021 | SEC↗ |
| AGN Allergan plc | M Exercise | 2017-12-01 | 2017-12-04 | 9,272 | $78.88 | $731.4K | 66,293 | SEC↗ |
| AGN Allergan plc | M Exercise | 2017-12-01 | 2017-12-04 | 2,535 | $78.88 | $200.0K | 68,828 | SEC↗ |
| AGN Allergan plc | S Sale | 2017-12-01 | 2017-12-04 | 9,272 | $173.89 | $1.61M | 59,556 | SEC↗ |
| AGN Allergan plc | M Exercise deriv | 2017-10-26 | 2017-10-30 | 9,321 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | M Exercise | 2017-10-26 | 2017-10-30 | 9,321 | — | $0 | 57,021 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2017-05-15 | 2017-05-16 | 587 | $228.22 | $134.0K | 47,700 | SEC↗ |
| AGN Allergan plc | A Award | 2017-04-03 | 2017-04-04 | 8,835 | $237.68 | $2.10M | 48,287 | SEC↗ |
| AGN Allergan plc | M Exercise deriv | 2016-12-08 | 2017-02-14 | 11,807 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | M Exercise | 2016-12-08 | 2017-02-14 | 11,807 | $109.12 | $1.29M | 48,866 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2016-12-08 | 2017-02-14 | 9,414 | $188.47 | $1.77M | 39,452 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2016-05-15 | 2016-05-17 | 510 | $223.35 | $113.9K | 37,059 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2016-05-15 | 2016-05-17 | 713 | $223.35 | $159.2K | 37,569 | SEC↗ |
| AGN Allergan plc | G Gift | 2015-12-23 | 2015-12-28 | 423 | — | $0 | 70,100 | SEC↗ |
| ACT Actavis plc | F Tax w/h | 2015-05-15 | 2015-05-19 | 671 | $296.60 | $199.0K | 70,523 | SEC↗ |
| ACT Actavis plc | F Tax w/h | 2015-05-15 | 2015-05-19 | 773 | $296.60 | $229.3K | 71,194 | SEC↗ |
| ACT Actavis plc | F Tax w/h | 2015-05-15 | 2015-05-19 | 437 | $296.60 | $129.6K | 71,967 | SEC↗ |
| ACT Actavis plc | F Tax w/h | 2015-04-01 | 2015-04-02 | 1,788 | $296.19 | $529.6K | 72,404 | SEC↗ |
| ACT Actavis plc | F Tax w/h | 2015-04-01 | 2015-04-02 | 3,848 | $296.19 | $1.14M | 74,192 | SEC↗ |
| ACT Actavis plc | G Gift | 2014-12-18 | 2014-12-22 | 98 | — | $0 | 78,040 | SEC↗ |
| ACT Actavis plc | F Tax w/h | 2014-12-06 | 2014-12-10 | 2,469 | $266.59 | $658.2K | 78,138 | SEC↗ |
| ACT Actavis plc | F Tax w/h | 2014-12-05 | 2014-12-10 | 1,332 | $266.59 | $355.1K | 80,607 | SEC↗ |
| ACT Actavis plc | M Exercise deriv | 2014-11-26 | 2014-12-01 | 7,083 | — | $0 | 0 | SEC↗ |
| ACT Actavis plc | M Exercise | 2014-11-26 | 2014-12-01 | 7,083 | $90.06 | $637.9K | 86,489 | SEC↗ |
| ACT Actavis plc | S Sale | 2014-11-26 | 2014-12-01 | 4,550 | $269.14 | $1.22M | 81,939 | SEC↗ |
| AGN Allergan plc | A Award | 2014-07-01 | 2016-03-04 | 47,165 | — | $0 | 47,165 | SEC↗ |
| FRX Forest Laboratories, LLC | A Award deriv | 2014-07-01 | 2014-07-03 | 13,310 | — | $0 | 13,310 | SEC↗ |
| FRX Forest Laboratories, LLC | A Award deriv | 2014-07-01 | 2014-07-03 | 24,000 | — | $0 | 24,000 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 26,053 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 1,079 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 45,780 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 2,640 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 21,362 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 2,938 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 34,049 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 1 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 41,892 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 3,108 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 36,802 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 24,000 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 5,855 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 4,145 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 19,632 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 5,368 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 25,000 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 2,352 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 12,648 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 13,310 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 3,198 | — | $0 | 0 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 21,253 | — | $0 | 21,253 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 21,184 | — | $0 | 21,184 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 12,814 | — | $0 | 12,814 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 22,868 | — | $0 | 22,868 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 11,476 | — | $0 | 11,476 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 16,081 | — | $0 | 16,081 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 19,278 | — | $0 | 19,278 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 18,892 | — | $0 | 18,892 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 4,723 | — | $0 | 4,723 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 11,807 | — | $0 | 11,807 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 11,807 | — | $0 | 11,807 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 7,084 | — | $0 | 7,084 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer | 2014-07-01 | 2014-07-03 | 35,590 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer | 2014-07-01 | 2014-07-03 | 55,882 | — | $0 | 0 | SEC↗ |
| ACT Actavis plc | A Award | 2014-07-01 | 2014-07-03 | 79,406 | — | $0 | 79,406 | SEC↗ |
| FRX FOREST LABORATORIES INC | F Tax w/h | 2014-05-15 | 2014-05-19 | 891 | $92.23 | $82.2K | 91,472 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award deriv | 2014-05-13 | 2014-05-16 | 27,132 | — | $0 | 27,132 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award | 2014-05-13 | 2014-05-16 | 8,519 | — | $0 | 92,363 | SEC↗ |
| FRX FOREST LABORATORIES INC | F Tax w/h | 2013-12-07 | 2013-12-10 | 3,698 | $56.34 | $208.3K | 83,844 | SEC↗ |
| FRX FOREST LABORATORIES INC | F Tax w/h | 2013-12-06 | 2013-12-10 | 4,747 | $56.34 | $267.4K | 87,542 | SEC↗ |
| FRX FOREST LABORATORIES INC | F Tax w/h | 2013-12-05 | 2013-12-09 | 2,038 | $55.87 | $113.9K | 92,289 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award deriv | 2013-05-21 | 2013-05-23 | 48,420 | — | $0 | 48,420 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award | 2013-05-21 | 2013-05-23 | 13,300 | — | $0 | 94,327 | SEC↗ |
| FRX FOREST LABORATORIES INC | F Tax w/h | 2013-05-15 | 2013-05-17 | 889 | $38.88 | $34.6K | 82,805 | SEC↗ |
| FRX FOREST LABORATORIES INC | M Exercise deriv | 2013-02-06 | 2013-02-08 | 11,350 | — | $0 | 34,050 | SEC↗ |
| FRX FOREST LABORATORIES INC | M Exercise deriv | 2013-02-06 | 2013-02-08 | 15,000 | — | $0 | 10,000 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2013-02-06 | 2013-02-08 | 200 | $35.86 | $7.2K | 82,616 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2013-02-06 | 2013-02-08 | 200 | $35.88 | $7.2K | 82,416 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2013-02-06 | 2013-02-08 | 500 | $35.89 | $17.9K | 81,916 | SEC↗ |
| FRX FOREST LABORATORIES INC | M Exercise | 2013-02-06 | 2013-02-08 | 15,000 | $24.12 | $361.8K | 96,916 | SEC↗ |
| FRX FOREST LABORATORIES INC | M Exercise | 2013-02-06 | 2013-02-08 | 11,350 | $30.00 | $340.5K | 108,266 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2013-02-06 | 2013-02-08 | 1,738 | $35.64 | $61.9K | 106,528 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2013-02-06 | 2013-02-08 | 9,048 | $35.65 | $322.6K | 97,480 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2013-02-06 | 2013-02-08 | 5,419 | $35.75 | $193.7K | 92,061 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2013-02-06 | 2013-02-08 | 100 | $35.78 | $3.6K | 91,961 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2013-02-06 | 2013-02-08 | 600 | $35.79 | $21.5K | 91,361 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2013-02-06 | 2013-02-08 | 2,400 | $35.80 | $85.9K | 88,961 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2013-02-06 | 2013-02-08 | 3,445 | $35.81 | $123.4K | 85,516 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2013-02-06 | 2013-02-08 | 1,300 | $35.82 | $46.6K | 84,216 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2013-02-06 | 2013-02-08 | 600 | $35.83 | $21.5K | 83,616 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2013-02-06 | 2013-02-08 | 400 | $35.84 | $14.3K | 83,216 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2013-02-06 | 2013-02-08 | 400 | $35.85 | $14.3K | 82,816 | SEC↗ |
| FRX FOREST LABORATORIES INC | F Tax w/h | 2012-12-08 | 2012-12-11 | 2,706 | $35.78 | $96.8K | 81,916 | SEC↗ |
| FRX FOREST LABORATORIES INC | F Tax w/h | 2012-12-07 | 2012-12-11 | 4,488 | $35.78 | $160.6K | 84,622 | SEC↗ |
| FRX FOREST LABORATORIES INC | F Tax w/h | 2012-12-06 | 2012-12-10 | 3,608 | $35.83 | $129.3K | 89,110 | SEC↗ |
| FRX FOREST LABORATORIES INC | F Tax w/h | 2012-12-05 | 2012-12-07 | 1,988 | $35.87 | $71.3K | 92,718 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award deriv | 2012-05-07 | 2012-05-09 | 24,300 | — | $0 | 24,300 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award | 2012-05-07 | 2012-05-09 | 7,300 | — | $0 | 94,706 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 100 | $32.02 | $3.2K | 120,205 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 536 | $32.01 | $17.2K | 120,305 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 413 | $32.00 | $13.2K | 120,841 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 8,000 | $32.00 | $256.0K | 121,254 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 100 | $32.21 | $3.2K | 87,406 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 600 | $32.20 | $19.3K | 87,506 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 500 | $32.19 | $16.1K | 88,106 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 600 | $32.18 | $19.3K | 88,606 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 2,026 | $32.03 | $64.9K | 118,179 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 2,762 | $32.04 | $88.5K | 115,417 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 500 | $32.04 | $16.0K | 114,917 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 2,300 | $32.05 | $73.7K | 112,617 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 6,288 | $32.05 | $201.5K | 106,329 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 2,544 | $32.06 | $81.6K | 103,785 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 4,300 | $32.06 | $137.9K | 99,485 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 2,500 | $32.07 | $80.2K | 96,785 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 200 | $32.07 | $6.4K | 99,285 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 200 | $32.08 | $6.4K | 96,585 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 939 | $32.09 | $30.1K | 95,646 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 1,100 | $32.10 | $35.3K | 94,546 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 100 | $32.11 | $3.2K | 94,446 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 1,400 | $32.13 | $45.0K | 93,046 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 896 | $32.14 | $28.8K | 92,150 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 1,643 | $32.15 | $52.8K | 90,507 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 701 | $32.16 | $22.5K | 89,806 | SEC↗ |
| FRX FOREST LABORATORIES INC | S Sale | 2012-01-18 | 2012-01-19 | 600 | $32.17 | $19.3K | 89,206 | SEC↗ |